10-K
File 000-52403
FORM 10-K FOR AUG 2025
- Filing date
- 01 Dec 2025
- Reporting date
- 31 Aug 2025
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
CNBX Pharmaceuticals Inc. reports
- Company location
- Bethesda, MD
- Fiscal year end
- 31 August
Company
Names, identifiers, and filing context for this profile.
1 identity field
SEC filing record 1 source field available
CNBX Pharmaceuticals Inc. has filed 300 SEC EDGAR filings since 09 Jan 2006
SEC filing history
Showing 1-20 of 20 matching filings.
Per page
25
Current page
1
10-K
File 000-52403
FORM 10-K FOR AUGUST 2024
- Filing date
- 29 Nov 2024
- Reporting date
- 31 Aug 2024
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 000-52403
FORM 10-K FOR AUG 2023
- Filing date
- 30 Nov 2023
- Reporting date
- 31 Aug 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 000-52403
FORM 10-K
- Filing date
- 30 Nov 2022
- Reporting date
- 31 Aug 2022
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 000-52403
10-K filing
- Filing date
- 29 Nov 2021
- Reporting date
- 31 Aug 2021
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 000-52403
ANNUAL REPORT
- Filing date
- 04 Nov 2020
- Reporting date
- 31 Aug 2020
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 000-52403
FORM 10-K
- Filing date
- 29 Nov 2019
- Reporting date
- 31 Aug 2019
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 000-52403
ANNUAL REPORT
- Filing date
- 29 Nov 2018
- Reporting date
- 31 Aug 2018
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 000-52403
FORM 10-K
- Filing date
- 08 Dec 2017
- Reporting date
- 31 Aug 2017
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K/A
File 000-52403
10-K/A
- Filing date
- 15 Mar 2017
- Reporting date
- 31 Aug 2016
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-K
File 000-52403
FORM 10-K
- Filing date
- 13 Dec 2016
- Reporting date
- 31 Aug 2016
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 000-52403
ANNUAL REPORT
- Filing date
- 07 Jan 2016
- Reporting date
- 31 Aug 2015
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K/A
File 000-52403
CANNABICS PHARMACEUTICALS INC.
- Filing date
- 23 Oct 2015
- Reporting date
- 31 Aug 2014
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 000-52403
FORM 10-K
- Filing date
- 15 Dec 2014
- Reporting date
- 31 Aug 2014
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K/A
File 000-52403
ANNUAL REPORT
- Filing date
- 09 Dec 2013
- Reporting date
- 31 Aug 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-K/A
File 000-52403
ANNUAL REPORT
- Filing date
- 29 Nov 2013
- Reporting date
- 31 Aug 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-K
File 000-52403
ANNUAL REPORT
- Filing date
- 29 Nov 2013
- Reporting date
- 31 Aug 2013
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 000-52403
ANNUAL REPORT
- Filing date
- 30 Nov 2012
- Reporting date
- 31 Aug 2012
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 000-52403
ANNUAL REPORT
- Filing date
- 29 Nov 2011
- Reporting date
- 31 Aug 2011
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 000-52403
ANNUAL REPORT
- Filing date
- 29 Nov 2010
- Reporting date
- 31 Aug 2010
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing